aod9604 human clinical trials weight loss results AOD 9604 vs. Semaglutide: A Comparison Peptide Series: What to Know

Break periods between cycles Between AOD-9604 cycles, a break period allows receptor sensitivity to restore and prevents potential adaptation that could reduce effectiveness in future cycles

For current information on peptide availability and regulatory changes, see our FDA peptide crackdown 2026 analysis

The insulin response from eating antagonizes the fat-releasing pathways the peptide activates

Doubling your dose does not double your results

AOD-9604, as a C-terminal fragment lacking affinity for the growth hormone receptor, avoids these metabolic complications

Adding 2ml of bacteriostatic water creates a concentration of 2.5mg/ml (2500mcg/ml)